PDS Biotechnology Corporation

PDS Biotechnology Corporationverified

PDSB

Price:

$3.08

Market Cap:

$112.97M

PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. Its lead product candidate is PDS0101 (HPV16), which is in Phase II clinical trial provides a first line treatment for the recurrent/metastatic head and neck cancer, human papillomavirus associated malignancies, and cervical cancer. The company is also developing various product candidates, which are in preclinical trials, including PDS0102 T-cell receptor gamma alternate reading frame protein (TARP) for treating prostate and breast cancers; PDS0103 (MUC-1) for ovarian, colorectal, lung, and breast cancers; and PDS0104, which include Tyrosinase-related prot...[Read more]

Industry

Biotechnology

IPO Date

2015-09-30

Stock Exchange

NASDAQ

Ticker

PDSB

The PE Ratio as of May 2024 (TTM) for PDS Biotechnology Corporation (PDSB) is -2.25

According to PDS Biotechnology Corporation’s latest financial reports and current stock price. The company's current PE Ratio is -2.25. This represents a change of -35.09% compared to the average of -3.47 of the last 4 quarters.

PDS Biotechnology Corporation (PDSB) Historical PE Ratio (quarterly & annually)

How has PDSB PE Ratio performed in the past?

The mean historical PE Ratio of PDS Biotechnology Corporation over the last ten years is -6.17. The current -2.25 PE Ratio has changed 3.55% with respect to the historical average. Over the past ten years (40 quarters), PDSB's PE Ratio was at its highest in in the March 2019 quarter at 1.08. The PE Ratio was at its lowest in in the June 2021 quarter at -123.39.

Quarterly (TTM)
Annual

Average

-6.17

Median

-4.60

Minimum

-13.62

Maximum

-0.25

PDS Biotechnology Corporation (PDSB) PE Ratio by Quarter and Year

Discovering the peaks and valleys of PDS Biotechnology Corporation PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 651.15%

Maximum Annual PE Ratio = -0.25

Minimum Annual Increase = -95.62%

Minimum Annual PE Ratio = -13.62

Quarterly (TTM)
Annual
YearPE RatioChange
2023-3.58-61.23%
2022-9.24-24.60%
2021-12.26407.77%
2020-2.4130.94%
2019-1.84651.15%
2018-0.25-95.62%
2017-5.60-39.75%
2016-9.29158.13%
2015-3.60-73.56%
2014-13.62-43.59%

PDS Biotechnology Corporation (PDSB) Average PE Ratio

How has PDSB PE Ratio performed in the past?

The current PE Ratio of PDS Biotechnology Corporation (PDSB) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-8.36

5-year avg

-5.87

10-year avg

-6.17

PDS Biotechnology Corporation (PDSB) PE Ratio vs. Peers

How is PDSB’s PE Ratio compared to its peers?

PDS Biotechnology Corporation’s PE Ratio is less than Mereo BioPharma Group plc (0), greater than Terns Pharmaceuticals, Inc. (-58.75), greater than Inozyme Pharma, Inc. (-4.90), greater than HOOKIPA Pharma Inc. (-3.66), less than eFFECTOR Therapeutics, Inc. (-2.11), less than Enveric Biosciences, Inc. (-0.21), less than CohBar, Inc. (-0.22), less than Ocean Biomedical, Inc. (-0.25), less than AVROBIO, Inc. (-0.25), less than X4 Pharmaceuticals, Inc. (2.23), less than Day One Biopharmaceuticals, Inc. (-1.40), greater than Elevation Oncology, Inc. (-5.71), greater than null (-4.62),

Build a custom stock screener for PDS Biotechnology Corporation (PDSB) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like PDS Biotechnology Corporation using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

PDS Biotechnology Corporation (PDSB) and other stocks custom spreadsheet templates

The easiest way to analyze a company like PDS Biotechnology Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is PDS Biotechnology Corporation's PE Ratio?

How is the PE Ratio calculated for PDS Biotechnology Corporation (PDSB)?

What is the highest PE Ratio for PDS Biotechnology Corporation (PDSB)?

What is the 3-year average PE Ratio for PDS Biotechnology Corporation (PDSB)?

What is the 5-year average PE Ratio for PDS Biotechnology Corporation (PDSB)?

How does the current PE Ratio for PDS Biotechnology Corporation (PDSB) compare to its historical average?